Steve Pakola sold $689K of RGNX stock

Steve Pakola, Chief Medical Officer of REGENXBIO Inc. (RGNX), sold 56,333 shares of RGNX stock worth $689K, per an SEC Form 4 filed Jul 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 29, 2026, 2 days before it was made public.

RGNX has moved -31.8% since the trade date, from $11.83 to $8.07 (Nov 9, 2026 close).